|
US5814651A
(en)
|
1992-12-02 |
1998-09-29 |
Pfizer Inc. |
Catechol diethers as selective PDEIV inhibitors
|
|
EP1308461A3
(en)
|
1993-01-25 |
2004-02-11 |
Takeda Chemical Industries, Ltd. |
Antibodies to beta-amyloids or their derivatives and use thereof
|
|
JPH08295667A
(ja)
*
|
1995-04-27 |
1996-11-12 |
Takeda Chem Ind Ltd |
複素環化合物、その製造法および剤
|
|
JPH08295687A
(ja)
*
|
1995-04-28 |
1996-11-12 |
Ube Ind Ltd |
無水シトラコン酸の製造法
|
|
DE19709877A1
(de)
|
1997-03-11 |
1998-09-17 |
Bayer Ag |
1,5-Dihydro-pyrazolo[3,4-d]-pyrimidinon-derivate
|
|
US8173127B2
(en)
|
1997-04-09 |
2012-05-08 |
Intellect Neurosciences, Inc. |
Specific antibodies to amyloid beta peptide, pharmaceutical compositions and methods of use thereof
|
|
CA2286305A1
(en)
|
1997-04-09 |
1998-10-15 |
Mindset Ltd. |
Recombinant antibodies specific for beta-amyloid ends, dna encoding and methods of use thereof
|
|
GB9722520D0
(en)
|
1997-10-24 |
1997-12-24 |
Pfizer Ltd |
Compounds
|
|
US6905686B1
(en)
|
1997-12-02 |
2005-06-14 |
Neuralab Limited |
Active immunization for treatment of alzheimer's disease
|
|
TWI239847B
(en)
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
|
CZ27399A3
(cs)
|
1999-01-26 |
2000-08-16 |
Ústav Experimentální Botaniky Av Čr |
Substituované dusíkaté heterocyklické deriváty, způsob jejich přípravy, tyto deriváty pro použití jako léčiva, farmaceutická kompozice a kombinovaný farmaceutický přípravek tyto deriváty obsahující a použití těchto derivátů pro výrobu léčiv
|
|
CA2390948A1
(en)
*
|
1999-06-03 |
2000-12-14 |
Abbott Laboratories |
Cell adhesion-inhibiting antiinflammatory compounds
|
|
EP1418175A1
(en)
|
1999-06-28 |
2004-05-12 |
Janssen Pharmaceutica N.V. |
Respiratory syncytial virus replication inhibitors
|
|
WO2001049688A1
(en)
|
2000-01-07 |
2001-07-12 |
Universitaire Instelling Antwerpen |
Purine derivatives, process for their preparation and use thereof
|
|
TR200202799T3
(tr)
|
2000-02-24 |
2003-03-21 |
Washington University St.Louis |
AB peptidini sekanslayan insanlaştırılmış antikorlar
|
|
JP3729343B2
(ja)
|
2000-04-27 |
2005-12-21 |
アステラス製薬株式会社 |
縮合ヘテロアリール誘導体
|
|
DE10045112A1
(de)
|
2000-09-11 |
2002-03-21 |
Merck Patent Gmbh |
Verwendung von Indolderivaten zur Behandlung von Erkrankungen des zentralen Nervensystems
|
|
AU2002239764B2
(en)
|
2000-11-03 |
2007-06-21 |
Proteotech, Inc. |
Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from uncaria tomentosa and related plants
|
|
GB0115181D0
(en)
|
2001-06-20 |
2001-08-15 |
Glaxo Group Ltd |
Novel use
|
|
WO2003000697A1
(en)
|
2001-06-22 |
2003-01-03 |
Takeda Chemical Industries, Ltd. |
Furoisoquinoline derivative, process for producing the same, and use
|
|
WO2003002118A1
(en)
|
2001-06-27 |
2003-01-09 |
Merck Frosst Canada & Co. |
Substituted 8-arylquinoline pde4 inhibitors
|
|
WO2003002511A1
(en)
|
2001-06-29 |
2003-01-09 |
Nikken Chemicals Co., Ltd. |
Cycloalkenone derivative
|
|
WO2003008396A1
(en)
|
2001-07-16 |
2003-01-30 |
Nikken Chemicals Co., Ltd. |
Optically active oxazine derivative
|
|
WO2003008392A1
(de)
|
2001-07-18 |
2003-01-30 |
Merck Patent Gmbh |
4-(benzyliden-amino)-3-(methylsulfanyl) -4h-(1, 2, 4) triazin-5-on derivate mit pde -iv hemmender und tnf-antagonistischer wirkung zur behandlung von herzkrankheiten und allergien
|
|
WO2003008373A1
(de)
|
2001-07-19 |
2003-01-30 |
Merck Patent Gmbh |
Tyrosinhydrazide
|
|
FR2827599A1
(fr)
|
2001-07-20 |
2003-01-24 |
Neuro3D |
Composes derives de quinoleine et quinoxaline,preparation et utilisations
|
|
GB0118373D0
(en)
|
2001-07-27 |
2001-09-19 |
Glaxo Group Ltd |
Novel therapeutic method
|
|
TWI221838B
(en)
|
2001-08-09 |
2004-10-11 |
Tanabe Seiyaku Co |
Pyrazinoisoquinoline compound or naphthalene compound
|
|
EP1285922A1
(en)
|
2001-08-13 |
2003-02-26 |
Warner-Lambert Company |
1-Alkyl or 1-cycloalkyltriazolo[4,3-a]quinazolin-5-ones as phosphodiesterase inhibitors
|
|
FR2828693B1
(fr)
|
2001-08-14 |
2004-06-18 |
Exonhit Therapeutics Sa |
Nouvelle cible moleculaire de la neurotoxicite
|
|
AU2002331621B2
(en)
|
2001-08-15 |
2008-06-05 |
Icos Corporation |
2H-phthalazin-1-ones and methods for use thereof
|
|
WO2003015789A2
(en)
|
2001-08-15 |
2003-02-27 |
Leo Pharma A/S |
A pharmaceutical composition for dermal application
|
|
EP1432444A4
(en)
|
2001-08-17 |
2005-11-02 |
Lilly Co Eli |
ANTI-BETA ANTIBODIES
|
|
JO2311B1
(en)
|
2001-08-29 |
2005-09-12 |
ميرك فروست كندا ليمتد |
Alkyl inhibitors Ariel phosphodiesterase-4
|
|
GB0122031D0
(en)
|
2001-09-12 |
2001-10-31 |
Pfizer Ltd |
Use of pde4 inhibitors in a dry powder inhaler
|
|
JP2005505570A
(ja)
|
2001-09-19 |
2005-02-24 |
アルタナ ファルマ アクチエンゲゼルシャフト |
Ｐｄｅ阻害剤及びロイコトリエン受容体拮抗物質の複合薬
|
|
IL160271A0
(en)
|
2001-09-19 |
2004-07-25 |
Altana Pharma Ag |
Pharmaceutical compositions containing pde4-inhibitors and nsaid
|
|
WO2003035650A1
(en)
|
2001-09-25 |
2003-05-01 |
Takeda Chemical Industries, Ltd. |
Entry inhibitor
|
|
WO2003029252A1
(en)
|
2001-10-02 |
2003-04-10 |
Pharmacia & Upjohn Company |
Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
|
|
GB0123951D0
(en)
|
2001-10-05 |
2001-11-28 |
Glaxo Group Ltd |
Therapies for treating respiratory diseases
|
|
DE10150517A1
(de)
|
2001-10-12 |
2003-04-17 |
Merck Patent Gmbh |
Verwendung von Phosphodiesterase IV-Inhibitoren
|
|
EP1435944B1
(en)
|
2001-10-16 |
2009-09-30 |
Memory Pharmaceutical Corporation |
4(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes
|
|
JP4397691B2
(ja)
|
2001-10-30 |
2010-01-13 |
コンフォーマ・セラピューティクス・コーポレイション |
Ｈｓｐ９０阻害活性を有するプリン類似体
|
|
HUP0401984A3
(en)
|
2001-10-31 |
2005-06-28 |
Merck Patent Gmbh |
Use of type 4 phosphodiesterase inhibitors for preparation of pharmaceutical compositions and combination with other active ingredients
|
|
US6833371B2
(en)
|
2001-11-01 |
2004-12-21 |
Icagen, Inc. |
Pyrazolopyrimidines
|
|
US20030195205A1
(en)
|
2001-11-02 |
2003-10-16 |
Pfizer Inc. |
PDE9 inhibitors for treating cardiovascular disorders
|
|
AR037517A1
(es)
|
2001-11-05 |
2004-11-17 |
Novartis Ag |
Derivados de naftiridinas, un proceso para su preparacion, composicion farmaceutica y el uso de los mismos para la preparacion de un medicamento para el tratamiento de una enfermedad inflamatoria
|
|
RU2302412C2
(ru)
|
2001-11-05 |
2007-07-10 |
Мерк Патент Гмбх |
Гидразоно-малонитрилы
|
|
US20030092706A1
(en)
|
2001-11-09 |
2003-05-15 |
Johannes Barsig |
Combination
|
|
IS7221A
(is)
|
2001-11-15 |
2004-04-15 |
Memory Pharmaceuticals Corporation |
Hringlaga adenosínmónófosfat fosfódíesterasa 4D7 ísóform og aðferðir til notkunar þeirra
|
|
FR2832711B1
(fr)
|
2001-11-26 |
2004-01-30 |
Warner Lambert Co |
Derives de triazolo [4,3-a] pyrido [2,3-d] pyrimidin-5-ones, compositions les contenant, procede de preparation et utilisation
|
|
US20050101000A1
(en)
|
2002-12-11 |
2005-05-12 |
Isis Pharmaceuticals Inc. |
Modulation of phosphodiesterase 4B expression
|
|
DE10238724A1
(de)
|
2002-08-23 |
2004-03-04 |
Bayer Ag |
Alkyl-substituierte Pyrazolpyrimidine
|
|
DE10238723A1
(de)
|
2002-08-23 |
2004-03-11 |
Bayer Ag |
Phenyl-substituierte Pyrazolyprimidine
|
|
WO2004032868A2
(en)
|
2002-10-09 |
2004-04-22 |
Rinat Neuroscience Corp. |
Methods of treating alzheimer's disease using antibodies directed against amyloid beta peptide and compositions thereof
|
|
AU2003283303A1
(en)
|
2002-11-08 |
2004-06-07 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4b (pde4b)
|
|
US7550470B2
(en)
|
2002-12-11 |
2009-06-23 |
Merck & Co. Inc. |
Substituted pyrazolo[1,5-A]pyrimidines as tyrosine kinase inhibitors
|
|
WO2004089471A2
(en)
|
2003-04-11 |
2004-10-21 |
Novo Nordisk A/S |
NEW PYRAZOLO[1,5-a] PYRIMIDINES DERIVATIVES AND PHARMACEUTICAL USE THEREOF
|
|
ES2338656T3
(es)
|
2003-04-11 |
2010-05-11 |
High Point Pharmaceuticals, Llc |
Uso farmaceutico de 1,2,4-triazoles fusionados.
|
|
US20040220186A1
(en)
|
2003-04-30 |
2004-11-04 |
Pfizer Inc. |
PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease
|
|
US7741341B2
(en)
|
2003-05-19 |
2010-06-22 |
Sanofi-Aventis Deutschland Gmbh |
Benzimidazole-derivatives as factor Xa inhibitors
|
|
WO2004110996A1
(en)
|
2003-06-19 |
2004-12-23 |
Pfizer Products Inc. |
Nk1 antagonist
|
|
AU2004253543B2
(en)
|
2003-07-01 |
2009-02-19 |
Merck & Co., Inc. |
Ophthalmic compositions for treating ocular hypertension
|
|
FR2857966A1
(fr)
|
2003-07-24 |
2005-01-28 |
Aventis Pharma Sa |
Produits aryl-heteroaromatiques, compositions les contenant et utilisation
|
|
US20050020587A1
(en)
|
2003-07-25 |
2005-01-27 |
Pfizer Inc |
Nicotinamide derivatives useful as PDE4 inhibitors
|
|
WO2005025616A1
(ja)
|
2003-09-09 |
2005-03-24 |
Takeda Pharmaceutical Company Limited |
抗体の用途
|
|
GB0322726D0
(en)
|
2003-09-27 |
2003-10-29 |
Glaxo Group Ltd |
Compounds
|
|
GB0322722D0
(en)
|
2003-09-27 |
2003-10-29 |
Glaxo Group Ltd |
Compounds
|
|
WO2005030787A2
(en)
|
2003-09-29 |
2005-04-07 |
Topigen Pharmaceutique Inc. |
Oligonucleotide compositions and methods for treating disease including inflammatory conditions
|
|
GB0327319D0
(en)
|
2003-11-24 |
2003-12-24 |
Pfizer Ltd |
Novel pharmaceuticals
|
|
US20050137234A1
(en)
|
2003-12-19 |
2005-06-23 |
Syrrx, Inc. |
Histone deacetylase inhibitors
|
|
BRPI0507374A
(pt)
|
2004-02-02 |
2007-07-10 |
Pfizer Prod Inc |
moduladores do receptor de histamina-3
|
|
AU2005325271A1
(en)
|
2004-05-06 |
2006-07-27 |
Plexxikon, Inc. |
PDE4B inhibitors and uses therefor
|
|
US7456164B2
(en)
|
2004-05-07 |
2008-11-25 |
Pfizer, Inc |
3- or 4-monosubtituted phenol and thiophenol derivatives useful as H3 ligands
|
|
EP1595881A1
(en)
|
2004-05-12 |
2005-11-16 |
Pfizer Limited |
Tetrahydronaphthyridine derivates useful as histamine H3 receptor ligands
|
|
KR20070040824A
(ko)
|
2004-07-30 |
2007-04-17 |
리나트 뉴로사이언스 코퍼레이션 |
아밀로이드-베타 펩티드에 대해 지시된 항체 및 이의 사용방법
|
|
JP2008512380A
(ja)
|
2004-09-03 |
2008-04-24 |
プレキシコン，インコーポレーテッド |
Ｐｄｅ４ｂ阻害剤
|
|
GB0420719D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
|
CN101083986A
(zh)
|
2004-09-20 |
2007-12-05 |
泽农医药公司 |
双环杂环衍生物及其作为硬脂酰CoA去饱和酶(SCD)抑制剂的用途
|
|
JP2008513508A
(ja)
|
2004-09-21 |
2008-05-01 |
シンタ ファーマシューティカルズ コーポレーション |
炎症及び免疫に関連する用途に用いる化合物
|
|
FR2877015B1
(fr)
|
2004-10-21 |
2007-10-26 |
Commissariat Energie Atomique |
Revetement nanostructure et procede de revetement.
|
|
DE102004054634A1
(de)
*
|
2004-11-12 |
2006-05-18 |
Schwarz Pharma Ag |
Azaindolcarboxamide
|
|
EP1827493A4
(en)
|
2004-12-22 |
2009-09-30 |
Univ St Louis |
USE OF ANTI-ABETA ANTIBODIES FOR THE TREATMENT OF BRAIN TRAUMA
|
|
JPWO2006088246A1
(ja)
|
2005-02-18 |
2008-07-10 |
武田薬品工業株式会社 |
Ｇｐｒ３４受容体機能調節剤
|
|
GB0503955D0
(en)
|
2005-02-25 |
2005-04-06 |
Glaxo Group Ltd |
Novel compounds
|
|
MY148086A
(en)
|
2005-04-29 |
2013-02-28 |
Rinat Neuroscience Corp |
Antibodies directed against amyloid-beta peptide and methods using same
|
|
BRPI0609225A2
(pt)
|
2005-05-12 |
2010-03-09 |
Pfizer |
formas cristalinas anidras de n-[1-(2-etoxietil)-5-(n-etil-n-metilamino)-7-(4-metilpiridi n-2-il-amino)-1h-pirazolo[4,3-d]pirimidina-3-carbonil] metanossulfonamida, composição farmacêutica compreendendo as mesmas e uso das mesmas
|
|
WO2006126083A1
(en)
|
2005-05-24 |
2006-11-30 |
Pharmacia & Upjohn Company Llc |
Pyridine [3 , 4-b] pyrazinone compounds as pde-5 inhibitors
|
|
WO2006126081A2
(en)
|
2005-05-24 |
2006-11-30 |
Pharmacia & Upjohn Company Llc |
Pyridino [2 , 3-b] pyrazinones as pde-5 inhibitors
|
|
CA2608672A1
(en)
|
2005-05-24 |
2006-11-30 |
Pharmacia & Upjohn Company Llc |
Pyridine [3,4-b] pyrazinones as pde-5 inhibitors
|
|
CA2607499C
(en)
|
2005-06-22 |
2010-11-30 |
Pfizer Products Inc. |
Histamine-3 receptor antagonists
|
|
US8158673B2
(en)
|
2005-10-27 |
2012-04-17 |
Pfizer Inc. |
Histamine-3 receptor antagonists
|
|
CA2624625A1
(en)
|
2005-11-04 |
2007-05-10 |
Pfizer Limited |
Tetrahydronaphthyridine derivative
|
|
WO2007063385A2
(en)
|
2005-12-01 |
2007-06-07 |
Pfizer Products Inc. |
Spirocyclic amine histamine-3 receptor antagonists
|
|
WO2007069053A1
(en)
|
2005-12-14 |
2007-06-21 |
Pfizer Products Inc. |
Benzimidazole antagonists of the h-3 receptor
|
|
WO2007088450A2
(en)
|
2006-02-01 |
2007-08-09 |
Pfizer Products Inc. |
Chromane antagonist of the h-3 receptor
|
|
WO2007088462A1
(en)
|
2006-02-01 |
2007-08-09 |
Pfizer Products Inc. |
Spirochromane antagonists of the h-3 receptor
|
|
WO2007099423A1
(en)
|
2006-03-02 |
2007-09-07 |
Pfizer Products Inc. |
1-pyrrolidine indane derivatives as histamine-3 receptor antagonists
|
|
EP2007749A2
(en)
|
2006-03-13 |
2008-12-31 |
Pfizer Products Inc. |
Tetralines antagonists of the h-3 receptor
|
|
GB0605462D0
(en)
|
2006-03-17 |
2006-04-26 |
Glaxo Group Ltd |
Novel compounds
|
|
HRP20110539T1
(hr)
|
2006-04-21 |
2011-08-31 |
Pfizer Products Inc. |
PIRIDINO[3,4-b]PIRAZINONI
|
|
WO2007138431A2
(en)
|
2006-05-30 |
2007-12-06 |
Pfizer Products Inc. |
Azabicyclic ether histamine-3 antagonists
|
|
US20080090834A1
(en)
|
2006-07-06 |
2008-04-17 |
Pfizer Inc |
Selective azole pde10a inhibitor compounds
|
|
US8138205B2
(en)
|
2006-07-07 |
2012-03-20 |
Kalypsys, Inc. |
Heteroarylalkoxy-substituted quinolone inhibitors of PDE4
|
|
WO2008006050A2
(en)
|
2006-07-07 |
2008-01-10 |
Govek Steven P |
Bicyclic heteroaryl inhibitors of pde4
|
|
AR063680A1
(es)
|
2006-08-04 |
2009-02-11 |
Merz Pharma Gmbh & Co Kgaa |
Derivados de pirazolo[1, 5-a]pirimidina, metodos e intermediario para su preparacion, composiciones farmaceuticas que los comprenden y su uso en la fabricacion de medicamentos para el tratamiento de enfermedades mediadas por la modulacion de mglur5.
|
|
EP1900739A1
(en)
|
2006-08-30 |
2008-03-19 |
Cellzome Ag |
Diazolodiazine derivatives as kinase inhibitors
|
|
WO2008033739A2
(en)
*
|
2006-09-12 |
2008-03-20 |
Neurogen Corporation |
Benzimidazole carboxamide derivatives
|
|
WO2008045664A2
(en)
|
2006-10-06 |
2008-04-17 |
Kalypsys, Inc. |
Heterocyclic pde4 inhibitors as antiinflammatory agents
|
|
US20100105729A1
(en)
|
2006-10-06 |
2010-04-29 |
Kalypsys, Inc. |
Aryl-substituted heterocyclic pde4 inhibitors as anti-inflammatory agents
|
|
US20080102475A1
(en)
|
2006-10-13 |
2008-05-01 |
Zhengyan Kan |
Alternatively spliced isoform of phosphodiesterase 4B (PDE4B)
|
|
CL2007002994A1
(es)
|
2006-10-19 |
2008-02-08 |
Wyeth Corp |
Compuestos derivados heterociclicos que contienen sulfamoilo, inhibidores de hsp90; composicion farmaceutica; y uso para el tratamiento del cancer, tal como cancer de mama, de colon y prostata, entre otros.
|
|
WO2008056176A1
(en)
|
2006-11-10 |
2008-05-15 |
Scottish Biomedical Limited |
Pyrazolopyrimidines as phosphodiesterase inhibitors
|
|
AU2008208653B2
(en)
|
2007-01-22 |
2012-11-22 |
Pfizer Products Inc. |
Tosylate salt of a therapeutic compound and pharmaceutical compositions thereof
|
|
KR20100066422A
(ko)
|
2007-08-10 |
2010-06-17 |
하. 룬트벡 아크티에 셀스카브 |
헤테로아릴 아미드 유사체
|
|
CA2695989A1
(en)
|
2007-08-10 |
2009-02-19 |
Glaxosmithkline Llc |
Certain nitrogen containing bicyclic chemical entities for treating viral infections
|
|
EP2085398A1
(en)
|
2008-02-01 |
2009-08-05 |
Merz Pharma GmbH & Co. KGaA |
Pyrazolopyrimidines, a process for their preparation and their use as medicine
|
|
WO2009108551A2
(en)
|
2008-02-25 |
2009-09-03 |
H. Lundbeck A/S |
Heteroaryl amide analogues
|
|
GB2461702A
(en)
|
2008-07-08 |
2010-01-13 |
Dyson Technology Ltd |
Hand drying apparatus
|
|
US9643922B2
(en)
|
2008-08-18 |
2017-05-09 |
Yale University |
MIF modulators
|
|
US8853125B2
(en)
|
2008-09-24 |
2014-10-07 |
Basf Se |
Pyrazole compounds for controlling invertebrate pests
|
|
WO2010059836A1
(en)
|
2008-11-20 |
2010-05-27 |
Decode Genetics Ehf |
Substituted aza-bridged bicyclics for cardiovascular and cns disease
|
|
US20100204265A1
(en)
|
2009-02-09 |
2010-08-12 |
Genelabs Technologies, Inc. |
Certain Nitrogen Containing Bicyclic Chemical Entities for Treating Viral Infections
|
|
PL2408446T3
(pl)
|
2009-03-20 |
2020-03-31 |
Hg&H Pharmaceuticals (Pty) Limited |
Zastosowanie kompozycji farmaceutycznych zawierających mesembrenon
|
|
KR101774035B1
(ko)
|
2009-10-30 |
2017-09-01 |
얀센 파마슈티카 엔.브이. |
이미다조［１，２―ｂ］피리다진 유도체 및 ＰＤＥ１０ 저해제로서의 그의 용도
|
|
RU2012126150A
(ru)
|
2009-11-25 |
2013-12-27 |
Мерц Фарма Гмбх Унд Ко. Кгаа |
Кристаллические формы замещенных пиразолопиримидинов
|
|
AR079451A1
(es)
|
2009-12-18 |
2012-01-25 |
Nycomed Gmbh |
Compuestos 3,4,4a,10b-tetrahidro-1h-tiopirano[4,3-c]isoquinolina
|
|
US8450354B2
(en)
|
2010-03-23 |
2013-05-28 |
High Point Pharmaceuticals, Llc |
Substituted imidazo[1,2-b]pyridazine derivatives, pharmaceutical compositions, and methods of use as β-secretase inhibitors
|
|
WO2011143106A1
(en)
|
2010-05-10 |
2011-11-17 |
Gilead Sciences, Inc. |
Bi - functional pyrazolopyridine compounds
|
|
AU2011253203A1
(en)
|
2010-05-10 |
2012-11-22 |
Gilead Sciences, Inc. |
Bifunctional quinoline derivatives
|
|
US8609669B2
(en)
|
2010-11-16 |
2013-12-17 |
Abbvie Inc. |
Potassium channel modulators
|
|
US9096605B2
(en)
|
2011-08-24 |
2015-08-04 |
Glaxosmithkline Llc |
Pyrazolopyrimidine derivatives as PI3 kinase inhibitors
|
|
MA38333A1
(fr)
*
|
2013-02-19 |
2017-02-28 |
Pfizer |
Composés d'azabenzimidazole en tant qu'inhibiteurs d'isozymes pde4 pour le traitement de troubles du snc et d'autres affections
|
|
US9193736B2
(en)
|
2013-06-11 |
2015-11-24 |
Janssen Pharmaceutica, Nv |
PDE 10a inhibitors for the treatment of type II diabetes
|
|
GB201321734D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic Agents
|
|
CN111772834B
(zh)
|
2014-03-21 |
2022-07-15 |
阿莱恩技术有限公司 |
具有弹性体的分段的正畸矫正器
|
|
WO2016012896A1
(en)
|
2014-07-24 |
2016-01-28 |
Pfizer Inc. |
Pyrazolopyrimidine compounds
|
|
SG11201700243YA
(en)
|
2014-08-06 |
2017-02-27 |
Pfizer |
Imidazopyridazine compounds
|